Clinical trials: Cutaneous Sarcoidosis, open to volunteers
Sarcoidosis, Cutaneous Sarcoidosis
Sirolimus in Cutaneous Sarcoidosis
Sarcoidosis is a multisystemic disease of unknown etiology characterized by the presence of epithelioid granulomas without caseous necrosis in the organs involved. Sarcoidosis cutaneous lesions can be severe.
- Trial name
- SIRIUS (NCT05458492)
- Testing
- Sirolimus
- Volunteers
- 10 people
- Sponsor
- Assistance Publique - Hôpitaux de Paris
Cutaneous Sarcoidosis
A Study of Brepocitinib in Adults With Cutaneous Sarcoidosis
This study will evaluate the clinical safety and efficacy of oral brepocitinib in participants with cutaneous sarcoidosis.
- Trial name
- BEACON (NCT06978725)
- Testing
- Oral Brepocitinib
- Where
- 44 sites in United States, Australia and 1 more
- Volunteers
- 168 people
- Sponsor
- Priovant Therapeutics, Inc.